Raymond James Financial Inc Amneal Pharmaceuticals, Inc. Transaction History
Raymond James Financial Inc
- $299 Billion
- Q3 2025
A detailed history of Raymond James Financial Inc transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 742,410 shares of AMRX stock, worth $8.64 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
742,410
Previous 714,332
3.93%
Holding current value
$8.64 Million
Previous $5.78 Million
28.61%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AMRX
# of Institutions
264Shares Held
152MCall Options Held
357KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA17.9MShares$208 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY12.3MShares$144 Million2.03% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$144 Million7.99% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$131 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.73MShares$66.7 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.76B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...